Odds Ratio (95%CI | ||||||||
---|---|---|---|---|---|---|---|---|
Contacts to GP | N (%) | Crude | Adjusted1 | Adjusted2 | ||||
Heart disease | 152 | (100%) | ||||||
No GP contacts | 37 | (19.4%) | 1 | 1 | 1 | |||
1-2 GP contacts | 90 | (59.4%) | 2.19 | (1.08;4.46) | 2.22 | (1.08;4.59) | 2.21 | (1.47;3.83) |
>2 GP contacts | 25 | (21.2%) | 1.41 | (0.59;3.41) | 1.56 | (1.29;3.71) | 1.54 | (0.51;4.64) |
Lung disease | 83 | (100%) | ||||||
No GP contacts | 28 | (24.6%) | 1 | 1 | 1 | |||
1-2 GP contacts | 41 | (52.9%) | 2.82 | (1.16;6.85) | 2.81 | (1.15;6.91) | 3.20 | (1.42;7.17) |
>2 GP contacts | 14 | (22.4%) | 1.34 | (0.42;4.26) | 1.34 | (0.42;4.25) | 1.49 | (1.08;2.05) |
Diabetes | 381 | (100%) | ||||||
No GP contacts | 109 | (24.0%) | 1 | 1 | 1 | |||
1-2 GP contacts | 197 | (53.1%) | 1.60 | (1.06;2.43) | 1.55 | (1.03;2.36) | 1.51 | (0.99;2.30) |
>2 GP contacts | 75 | (22.9%) | 1.74 | (1.02;2.94) | 1.56 | (0.90;2.70) | 1.54 | (0.89;2.68) |
Psychiatric disease | 131 | (100%) | ||||||
No GP contacts | 57 | (38.7%) | 1 | 1 | 1 | |||
1-2 GP contacts | 49 | (37.3%) | 0.99 | (0.49;1.99) | 0.96 | (0.48;1.97) | 0.98 | (0.48;2.01) |
>2 GP contacts | 25 | (24.0%) | 2.38 | (0.99;5.71) | 2.09 | (0.99;5.14) | 2.15 | (1.00;5.39) |
Cancer | 336 | (100%) | ||||||
No GP contacts | 103 | (23.9%) | 1 | 1 | 1 | |||
1-2 GP contacts | 170 | (52.6%) | 1.65 | (1.07;2.54) | 1.61 | (1.04;2.50) | 1.56 | (1.01;2.43) |
>2 GP contacts | 63 | (22.2%) | 2.39 | (1.37;4.16) | 2.19 | (1.22;3.94) | 2.17 | (1.20;3.91) |
2 + diagnose | 205 | (100%) | ||||||
No GP contacts | 58 | (25.4%) | 1 | 1 | 1 | |||
1-2 GP contacts | 104 | (52.8%) | 1.53 | (0.82;2.83) | 1.51 | (0.82;2.78) | 1.49 | (0.81;2.76) |
>2 GP contacts | 43 | (21.8%) | 1.78 | (0.84;3.75) | 1.63 | (0.75;3.54) | 1.63 | (0.75;3.56) |
Annual follow-up | Crude | Adjusted 1 | Adjusted 2 | |||||
Heart disease | 152 | (100%) | ||||||
No annual follow-up | 120 | (81.2%) | 1 | 1 | 1 | |||
Annual follow-up | 32 | (18.8%) | 0.82 | (0.39;1.73) | 0.84 | (0.40;1.78) | 0.83 | (0.39;1.75) |
Lung disease | 83 | (100%) | ||||||
No annual follow-up | 71 | (80.7%) | 1 | 1 | 1 | |||
Annual follow-up | 12 | (19.3%) | 0.71 | (0.21;2.41) | 0.70 | (0.20;2.48) | 0.68 | (0.19;2.43) |
Diabetes | 381 | (100%) | ||||||
No annual follow-up | 284 | (73.2%) | 1 | 1 | 1 | |||
Annual follow-up | 97 | (26.8%) | 1.07 | (0.71;1.62) | 1.0 | (0.65;1.51) | 0.98 | (0.66;1.55) |
Psychiatric disease | 131 | (100%) | ||||||
No annual follow-up | 115 | (88.0%) | 1 | 1 | 1 | |||
Annual follow-up | 16 | (12.0%) | 0.59 | (0.20;1.74) | 0.48 | (0.17;1.40) | 0.42 | (0.14;1.25) |
Cancer | 336 | (100%) | ||||||
No annual follow-up | 280 | (82.8%) | 1 | 1 | 1 | |||
Annual follow-up | 56 | (17.2%) | 1.00 | (0.58;1.71) | 0.92 | (0.53;1.58) | 0.91 | (0.52;1.58) |
2 + diagnose | 205 | (100%) | ||||||
No annual follow-up | 154 | (78.9%) | 1 | 1 | 1 | |||
Annual follow-up | 51 | (21.1%) | 0.83 | (0.62;1.12) | 0.63 | (0.34;1.17) | 0.61 | (0.33;1.13) |